Breast Biopsy Market to Reach $1.08 Bn, Globally, by 2030 at 5.1% CAGR: Allied Market Research

News provided by

Apr 04, 2022, 09:10 ET

Increased sensitivity of women to mammary cancer in all countries, as well as awareness campaigns and screenings done in their favor drive the growth of the global breast biopsy market.

PORTLAND, Ore., April 4, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Breast Biopsy Market by Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), by Image Guided Technology (Mri Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Ct Guided Biopsy, Other Image Guided Breast Biopsy), by End User (Hospitals And Clinics, Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global breast biopsy industry was estimated at $658.17 million in 2020, and is anticipated to hit $1.08 billion by 2030, registering a CAGR of 5.1% from 2021 to 2030.

For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1067

Drivers, restraints, and opportunities-

Increased sensitivity of women to mammary cancer in all countries, as well as awareness campaigns and screenings done in their favor drive the growth of the global breast biopsy market. On the other hand, incidences of adverse effects and infections after the biopsy restrain the growth to some extent. However, several government initiatives taken toward the development of diagnostic technologies are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

Due to the ongoing lockdowns in several nations to prevent the spread of the Covid-19 virus, especially during the initial period, hospitals, clinics, and diagnostic facilities were unable to deliver biopsy services. This, in turn, impacted the breast biopsy market negatively.
Also, the pandemic led to a steep decline in the number of breast cancer check-ups. However, the market has already started recovering and is projected to get back on track soon.

The core needle biopsy segment to dominate by 2030-

On the basis of product, the core needle biopsy segment accounted for the highest market share in 2020, generating more than half of the global breast biopsy market. Surge in breast cancer has created a demand for precise diagnostic technology which has eventually resulted in the growth of the core needle biopsy procedure. The vacuum assisted biopsy segment, however, is anticipated to cite the fastest CAGR of 6.4% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1067

The hospitals and clinics segment to maintain its lion's share-

On the basis of end use type, the hospitals & clinics segment generated the highest share in 2020, holding more than half of the global breast biopsy market. The diagnostic centers segment, on the other hand, is expected to cite the fastest CAGR of 6.0% from 2021 to 2030. This is attributed to the emergence of prioritizing imaging technology for breast cancer detection.

North America garnered the highest share in 2020-

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global breast biopsy market. Rise in cancer cases and steps undertaken by government to provide facilities for early diagnosis of cancer drive the market growth in the region. The Asia-Pacific region, simultaneously, is projected to cite the fastest CAGR of 7.1% from 2021 to 2030, due to surge in awareness and technological advancements in the breast healthcare sector.

Key players in the industry-

Intact Medical Corporation
Galini SRL
Hologic Inc.
Ethicon Endo Surgery
Becton and Dickinson Company
Encapsule medical Devices LLC.
Leica Biosystems Nussloch GmbH
C. R. Bard, Inc.
Argon Medical Devices
Cook Medical Incorporated

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Digital Health Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Oncology/Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Enzyme Replacement Therapy Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Healthcare CRM Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Hospital-Acquired Infection Control Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Pneumonia Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/